NANOPARTICLE DRUG CONJUGATES - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Serial Number
86613156
Word Mark
NANOPARTICLE DRUG CONJUGATES
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2017-05-05
Filing Date
2015-04-28
Mark Drawing
4000 - Standard character mark
Typeset
Attorney Name
Law Office Assigned Location Code
L40
Employee Name
PARK, JENNY K
Statements
Goods and Services
pharmaceutical preparations and substances for diagnosis and targeted treatment of cancer and tumor diseases; pharmaceutical preparations and substances for diagnosis and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; therapeutic agents for diagnosis and targeted treatment of cancer and tumor diseases; therapeutic agents for diagnosis and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; therapeutic pharmaceuticals and substances for the diagnosis and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations and substances for diagnosis and treatment of diseases and disorders; therapeutic agents for diagnosis and treatment of diseases and disorders
Goods and Services
research and development in the fields of pharmaceuticals, biotechnology, therapeutics, and drug formulation and delivery; research and development in the field of targeted therapies for cancer and tumor diseases; research and development in the field of targeted therapies for viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders; consulting services in the field of scientific research; consulting services in the field of research and development for pharmaceuticals, biotechnology, therapeutics, and drug formulation and delivery; consulting services in the field of clinical trials; testing, inspection, research, or development of pharmaceutical and therapeutic preparations; pharmaceutical and therapeutic drug development services; pharmaceutical and therapeutic product evaluation; conducting early evaluations in the field of new pharmaceuticals and therapeutics; conducting quality control testing, feasibility testing, toxicology testing and pharmacology testing for pharmaceuticals and therapeutics; laboratory research services relating to pharmaceuticals and therapeutics; medical and scientific research, namely, conducting clinical trials for others; product safety testing for pharmaceuticals and therapeutics
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2015-05-09
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
7 - Inactive - Insufficient fee received
Class Status Date
2015-05-09
Primary Code
042
Correspondences
Name
ELIZABETH A. WALKER
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2015-05-01 | NEW APPLICATION ENTERED IN TRAM |
| 2015-05-09 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2015-08-06 | ASSIGNED TO EXAMINER |
| 2015-08-12 | NON-FINAL ACTION WRITTEN |
| 2015-08-12 | NON-FINAL ACTION E-MAILED |
| 2015-08-12 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2016-02-11 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2016-02-11 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2016-02-12 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2016-03-04 | NON-FINAL ACTION WRITTEN |
| 2016-03-04 | NON-FINAL ACTION E-MAILED |
| 2016-03-04 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2016-09-02 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2016-09-10 | ASSIGNED TO LIE |
| 2016-09-16 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2016-09-16 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2016-10-07 | FINAL REFUSAL WRITTEN |
| 2016-10-07 | FINAL REFUSAL E-MAILED |
| 2016-10-07 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 2017-05-05 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 2017-05-05 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
